Clinical trial Recruiting at 1 site Interventional Ages 18 to 25

Youth suicide risk factors and personalized reduction strategies in young adults

Official title: Youth Suicide Risk Factors: Clinical, Neuroimaging, Genetic, and Microbiome Insights, and Predictors of Response to Deep Transcranial Magnetic Stimulation (dTMS)

Run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07188506 · Data updated 2026-11-12

This study tests whether combining clinical data, genetic information, neuroimaging, and microbiome data can help identify risk factors and see if a dTMS-based intervention reduces suicide risk in young adults with mood disorders.

More Suicide Prevention trials

Quick facts

Study typeInterventional
Ages18 Years to 25 Years
SexAll
Enrollment180 (estimated)
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
Academic / other
Locations1 site (Roma, RM)
StatusRecruiting
StartedNovember 15, 2025
Main results expectedDecember 31, 2027
Study endsOctober 31, 2028
Registry record updatedAugust 28, 2026
Trial IDNCT07188506 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are 18–25 years old with a mood disorder (depression or bipolar) who can undergo MRI and speak Italian.

Probably not a fit

Individuals with severe neurological conditions, cognitive impairment, inability to consent, or non-Italian speakers may not benefit from the study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

YOU-SURF aims to integrate multimodal data to identify risk factors for suicide in youth and test a dTMS-based intervention. The study includes clinical assessments, blood tests, genome-wide genotyping, and neuroimaging, alongside an innovative neuromodulation treatment. It compares participants with mood disorders aged 18–25 to a control group without DSM-5 disorders, all undergoing MRI and Italian-language screening. The approach targets personalized risk profiling and tailored treatment strategies based on multiple biological and clinical dimensions.

Why it matters

Potential benefit: If successful, participants could receive more effective, individualized risk reduction strategies for suicidal thoughts or behaviors.

How similar studies have gone: Previous studies have shown promise with multimodal approaches, but this project is among the first to combine multimodal data with dTMS in youth.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of mood disorder (major depressive episode, major depressive disorder, or bipolar disorder) according to DSM-5;
* Age between 18 and 25 years;
* Eligibility for magnetic resonance imaging;
* Proficiency in the Italian language.

Exclusion Criteria:

* Comorbidity with severe neurological or medical conditions;
* Diagnosis of cognitive impairment;
* Inability to provide informed consent.

For the control group:

Inclusion Criteria:

the same as the experimental group.

Exclusion Criteria:

* subjects with DSM-5 disorders
* subjects with a family history of psychiatric disorders will be excluded.

Where it's running

  • Fondazione Policlinico Universitario A. Gemelli IRCCS - UOC Psichiatria Clinica e d'Urgenza
    Roma, Rm, Italy
    Recruiting

Study contacts

  • Principal investigator: Delfina Janiri — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
  • Study coordinator: Delfina Janiri
  • Email: delfina.janiri@unicatt.it
  • Phone: +390630159527

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.